Cargando…
How Computational Chemistry and Drug Delivery Techniques Can Support the Development of New Anticancer Drugs
The early and late development of new anticancer drugs, small molecules or peptides can be slowed down by some issues such as poor selectivity for the target or poor ADME properties. Computer-aided drug design (CADD) and target drug delivery (TDD) techniques, although apparently far from each other,...
Autores principales: | Garofalo, Mariangela, Grazioso, Giovanni, Cavalli, Andrea, Sgrignani, Jacopo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180704/ https://www.ncbi.nlm.nih.gov/pubmed/32290224 http://dx.doi.org/10.3390/molecules25071756 |
Ejemplares similares
-
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity
por: Fassi, Enrico Mario Alessandro, et al.
Publicado: (2022) -
Biological Characterization of Computationally Designed Analogs of peptide TVFTSWEEYLDWV (Pep2-8) with Increased PCSK9 Antagonistic Activity
por: Lammi, Carmen, et al.
Publicado: (2019) -
Structural Biology of STAT3 and Its Implications for Anticancer Therapies Development
por: Sgrignani, Jacopo, et al.
Publicado: (2018) -
Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex
por: Fassi, Enrico M.A., et al.
Publicado: (2019) -
How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study
por: Sgrignani, Jacopo, et al.
Publicado: (2018)